MediGene to Present at the Needham Biotech Conference in New York
MediGene to Present at the Needham Biotech Conference in New York PharmaLive.com (press release), PA - Jun 7, 2006 in the US (Polyphenon E Ointment for the treatment of genital MediGene's innovative oncolytic HSV (cancer-destroying herpes simplex viruses) are modified for Relapsing multiple sclerosis: FDA has approved the reintroduction Xagena.it, Italy - Jun 5, 2006 Herpes infections were slightly more common in patients treated with Tysabri. adverse events in clinical trials were similarly balanced between treatment groups Category: Fairway Woods Golf-Gear-Review.com (press release), PA - Jun 7, 2006 Fluconazole Symptoms of herpes [url]http://w.ddt.michikusa.jp/symptoms-of-herpes.html[/url] [url]http://y.ddt.michikusa.jp/hemorrhoids-treatment.html[/url One Disease, Two Epidemics AIDS at 25 New England Journal of Medicine (subscription), MA - Jun 7, 2006 one fifth of people in developing countries who need treatment are receiving of HIV transmission, long-term antiviral therapy for genital herpes simplex a Chlamydia strikes hard at under-25s The Herald, UK - Jun 7, 2006 This has boosted hopes that more patients will receive treatment before the is by far the most common STD, but others - gonorrhea, genital herpes and syphilis FDA Approves the Reintroduction of TYSABRI(R) for the Treatment of Finanzen.net, Germany - Jun 5, 2006 Herpes infections were slightlymore common in patients treated with TYSABRI. eventsin clinical trials were similarly balanced between treatment groups.Serious
<< Home